FDA clears STERIS system
On April 5, the U.S. Food and Drug Administration cleared the STERIS System 1E Liquid Chemical Sterilant Processing System. The device is used to…
Technology
New online resource: Genetic/Genomic Competency Center
The Genetic/Genomic Competency Center (G2C2, http://www.g-2-c-2.org/) is a new free online resource created to help educators teach the next generation of nurses and physician…
“Metal-on-metal” hip implant concerns on the rise
The New York Times published an article on concerns related to “metal-on-metal” hip implants. Read the article at http://www.nytimes.com/2010/03/04/health/04metalhip.html?partner=rss&emc=rss.
New colorectal screening guidelines
Screening for colorectal cancer is still underused, especially by low-income people, the uninsured, Asians and Hispanics, foreign-born people, and those with limited English-language skills…
Early imaging reduces length of stay
According to the study “Patients Imaged Early During Admission Demonstrate Reduced Length of Hospital Stay: A Retrospective Cohort Study of Patients Undergoing Cross-Sectional Imaging,”…
FDA approves new implanted hearing system
On March 17, the U.S. Food and Drug Administration announced the approval of the Esteem, an implanted hearing system for moderate to severe sensorineural…
Counterfeit surgical mesh
On March 11, the U.S. Food and Drug Administration issued a warning about counterfeit surgical mesh being distributed under C. R. Bard/Davol brand name.…
Brought to you by NDNQI: Data that do good
Thanks to the National Database of Nursing Quality Indicators, hospitals and nurses are capturing and converting into data what nurses actually do and how…
Applying a systematic approach to new-product assessment
Take the spontaneity out of new-product purchases to control costs and keep patients safe.
The US Food and Drug Administration has approved two drugs
Morphine Sulfate Oral Solution, used to relieve moderate to severe pain in patients tolerant to opioids. liraglutide (Victoza), a once-daily injection for treating type…
Drug approval for breast cancer
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer…
Implantable cardioverter-defibrillator: Not just another device
Increasing numbers of patients at risk for sudden cardiac death are receiving ICDs for primary prevention. This article explains how ICD therapy has grown…
FDA clears STERIS system
On April 5, the U.S. Food and Drug Administration cleared the STERIS System 1E Liquid Chemical Sterilant Processing System. The device is…
New online resource: Genetic/Genomic Competency Center
The Genetic/Genomic Competency Center (G2C2, http://www.g-2-c-2.org/) is a new free online resource created to help educators teach the next generation of nurses…
“Metal-on-metal” hip implant concerns on the rise
The New York Times published an article on concerns related to “metal-on-metal” hip implants. Read the article at http://www.nytimes.com/2010/03/04/health/04metalhip.html?partner=rss&emc=rss.
New colorectal screening guidelines
Screening for colorectal cancer is still underused, especially by low-income people, the uninsured, Asians and Hispanics, foreign-born people, and those with limited…
Early imaging reduces length of stay
According to the study “Patients Imaged Early During Admission Demonstrate Reduced Length of Hospital Stay: A Retrospective Cohort Study of Patients Undergoing…
FDA approves new implanted hearing system
On March 17, the U.S. Food and Drug Administration announced the approval of the Esteem, an implanted hearing system for moderate to…
Counterfeit surgical mesh
On March 11, the U.S. Food and Drug Administration issued a warning about counterfeit surgical mesh being distributed under C. R. Bard/Davol…
Brought to you by NDNQI: Data that do good
Thanks to the National Database of Nursing Quality Indicators, hospitals and nurses are capturing and converting into data what nurses actually do…
Applying a systematic approach to new-product assessment
Take the spontaneity out of new-product purchases to control costs and keep patients safe.
The US Food and Drug Administration has approved two drugs
Morphine Sulfate Oral Solution, used to relieve moderate to severe pain in patients tolerant to opioids. liraglutide (Victoza), a once-daily injection for…
Drug approval for breast cancer
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced…
Implantable cardioverter-defibrillator: Not just another device
Increasing numbers of patients at risk for sudden cardiac death are receiving ICDs for primary prevention. This article explains how ICD therapy…
Test Your Knowledge
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.